2-50538274-G-T

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001330078.2(NRXN1):​c.2122C>A​(p.Leu708Ile) variant causes a missense change. The variant allele was found at a frequency of 0.00499 in 1,612,464 control chromosomes in the GnomAD database, including 31 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0045 ( 3 hom., cov: 32)
Exomes 𝑓: 0.0050 ( 28 hom. )

Consequence

NRXN1
NM_001330078.2 missense

Scores

1
6
12

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 4.92
Variant links:
Genes affected
NRXN1 (HGNC:8008): (neurexin 1) This gene encodes a single-pass type I membrane protein that belongs to the neurexin family. Neurexins are cell-surface receptors that bind neuroligins to form Ca(2+)-dependent neurexin/neuroligin complexes at synapses in the central nervous system. This complex is required for efficient neurotransmission and is involved in the formation of synaptic contacts. Three members of this gene family have been studied in detail and are estimated to generate over 3,000 variants through the use of two alternative promoters (alpha and beta) and extensive alternative splicing in each family member. Recently, a third promoter (gamma) was identified for this gene in the 3' region. Mutations in this gene are associated with Pitt-Hopkins-like syndrome-2 and may contribute to susceptibility to schizophrenia. [provided by RefSeq, Aug 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.014493406).
BP6
Variant 2-50538274-G-T is Benign according to our data. Variant chr2-50538274-G-T is described in ClinVar as [Likely_benign]. Clinvar id is 93589.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-50538274-G-T is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.00446 (679/152296) while in subpopulation AMR AF= 0.007 (107/15290). AF 95% confidence interval is 0.00604. There are 3 homozygotes in gnomad4. There are 333 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 3 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
NRXN1NM_001330078.2 linkuse as main transcriptc.2122C>A p.Leu708Ile missense_variant 10/23 ENST00000401669.7 NP_001317007.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
NRXN1ENST00000401669.7 linkuse as main transcriptc.2122C>A p.Leu708Ile missense_variant 10/235 NM_001330078.2 ENSP00000385017 A1

Frequencies

GnomAD3 genomes
AF:
0.00446
AC:
679
AN:
152178
Hom.:
3
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00101
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00701
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00124
Gnomad FIN
AF:
0.00622
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00654
Gnomad OTH
AF:
0.00621
GnomAD3 exomes
AF:
0.00384
AC:
954
AN:
248338
Hom.:
6
AF XY:
0.00395
AC XY:
532
AN XY:
134646
show subpopulations
Gnomad AFR exome
AF:
0.000840
Gnomad AMR exome
AF:
0.00325
Gnomad ASJ exome
AF:
0.000200
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00151
Gnomad FIN exome
AF:
0.00554
Gnomad NFE exome
AF:
0.00569
Gnomad OTH exome
AF:
0.00381
GnomAD4 exome
AF:
0.00505
AC:
7373
AN:
1460168
Hom.:
28
Cov.:
31
AF XY:
0.00506
AC XY:
3675
AN XY:
726064
show subpopulations
Gnomad4 AFR exome
AF:
0.000688
Gnomad4 AMR exome
AF:
0.00362
Gnomad4 ASJ exome
AF:
0.000153
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00138
Gnomad4 FIN exome
AF:
0.00497
Gnomad4 NFE exome
AF:
0.00585
Gnomad4 OTH exome
AF:
0.00489
GnomAD4 genome
AF:
0.00446
AC:
679
AN:
152296
Hom.:
3
Cov.:
32
AF XY:
0.00447
AC XY:
333
AN XY:
74472
show subpopulations
Gnomad4 AFR
AF:
0.00101
Gnomad4 AMR
AF:
0.00700
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00124
Gnomad4 FIN
AF:
0.00622
Gnomad4 NFE
AF:
0.00654
Gnomad4 OTH
AF:
0.00614
Alfa
AF:
0.00518
Hom.:
6
Bravo
AF:
0.00412
TwinsUK
AF:
0.00593
AC:
22
ALSPAC
AF:
0.00441
AC:
17
ESP6500AA
AF:
0.00101
AC:
4
ESP6500EA
AF:
0.00722
AC:
60
ExAC
AF:
0.00388
AC:
469
Asia WGS
AF:
0.00144
AC:
5
AN:
3478
EpiCase
AF:
0.00649
EpiControl
AF:
0.00760

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Benign, criteria provided, single submitterclinical testingGeneDxApr 30, 2019This variant is associated with the following publications: (PMID: 23769996, 28289584, 18179900, 21288692, 18728070, 23935565) -
Benign, criteria provided, single submitterclinical testingCenter for Pediatric Genomic Medicine, Children's Mercy Hospital and ClinicsJul 13, 2016- -
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenFeb 01, 2024NRXN1: BS2 -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsDec 30, 2017- -
not specified Benign:2
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Jul 25, 2012- -
Benign, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoFeb 23, 2015- -
Pitt-Hopkins-like syndrome 2 Benign:2
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 29, 2024- -
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsSep 22, 2021This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.16
BayesDel_addAF
Benign
-0.25
T
BayesDel_noAF
Benign
-0.13
CADD
Uncertain
24
DANN
Uncertain
0.99
DEOGEN2
Benign
0.29
.;T;.;.;T;.;.;T
Eigen
Uncertain
0.30
Eigen_PC
Uncertain
0.42
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Uncertain
0.94
D;D;D;D;D;D;D;D
M_CAP
Benign
0.015
T
MetaRNN
Benign
0.014
T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.46
T
MutationAssessor
Benign
0.28
.;N;.;.;.;.;.;.
MutationTaster
Benign
0.62
N;N;N;N;N;N
PrimateAI
Pathogenic
0.86
D
PROVEAN
Benign
-1.1
.;N;N;N;.;.;N;.
REVEL
Uncertain
0.30
Sift
Benign
0.30
.;T;T;T;.;.;D;.
Sift4G
Benign
0.21
T;T;T;T;T;T;T;T
Polyphen
0.57
.;.;P;.;.;.;.;.
Vest4
0.51
MVP
0.41
MPC
0.64
ClinPred
0.010
T
GERP RS
5.1
Varity_R
0.27
gMVP
0.22

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.10
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs56086732; hg19: chr2-50765412; COSMIC: COSV58453863; COSMIC: COSV58453863; API